Global Community

Key Assumptions & Valuation Logic: Net Asset Value (NAV) Revaluation: Baseline Q2 2026 NAV of NOK 1,429 per share is adjusted upward to reflect the implied market valuation of AI infrastructure provider Nscale at a target IPO valuation of $25B (~NOK 262.5B). Nscale Ownership Contribution: Aker’s 22.7% stake in Nscale is valued at ~NOK 59.6B (~NOK 802/share).Read more

Couche-Tard sits inside the top tenth of the TGI watchlist on the primary rank and higher still on dividend growth, with a payout ratio near ten percent. It arrived there in the same three months it agreed to acquire Poland's Żabka Group for approximately US$8.6 billion, the largest acquisition in its history, funded entirely with debt, and the first network it has promised not to absorb.Read more

Investors have recently been forced to process two very different versions of ASML. The first is a company whose demand outlook is improving fast enough for management to lift 2026 sales guidance to €43–45bn and gross-margin guidance to 54–56%.Read more

Meta’s core apps keep throwing off huge cash, and the story says new AI tools are making its ads more useful for businesses—while WhatsApp and Threads open fresh ways to grow beyond the old Facebook model. It also flags a big bet on smart glasses and heavy spending that could pay off, but could just as easily drag on results if adoption takes longer than expected.Read more

Right Now Reddit is sitting at $136.38. It closed at $226.17 the day before.Read more

ResMed (ASX: RMD) – 12-Month Investment Thesis (August 2026) Rating: BUY (close to Strong Buy if shares remain around current levels) 12-month Target Price: A$38–41 Estimated Upside: ~20–30% (depending on current share price) Confidence: High Investment Summary ResMed is one of the highest-quality healthcare companies listed on the ASX. Despite investor concerns around obesity drugs (GLP-1 medications such as Zepbound and Wegovy), the company’s operating performance has remained exceptionally strong.Read more

Business Overview Key Metrics Total: 5/17 +2 ✅✅ Projected Operating Margin: 40.00% +0 ⚠️ Projected 5-Year Revenue CAGR: 9.00% +1 ✅ Last 5-Year ROIC: 19.98% +1 ✅ Estimated Cost of Capital: 8.80% (less than ROIC) +1 ✅ Last 5-Year Shares Outstanding CAGR: -0.95% +1 ✅ Projected 5-Year EPS CAGR: 15.91% +0 ⚠️ Projected 5-Year Dividend CAGR: N/A +1 ✅ Moody's Rating: A2 -1 ❌ Morningstar Moat: Narrow -1 ❌ Morningstar Uncertainty: High Netflix has become synonymous with watching movies. Its ever- growing catalog of movies and series locks in its users creating a business that has very high margins.Read more

(This story appeared on my substack page around a week ago - https://piproberts25.substack.com/p/aristocrat-leisure-the-hidden-moat?r=6kjdcg ) Aristocrat Leisure (ASX) is a high-quality, cash-generative business with a durable competitive moat and attractive long-term growth prospects. Once known primarily as a poker machine manufacturer, the company has steadily transformed itself into a global gaming technology business with operations spanning land-based gaming, social casino games, online gaming and iGaming platforms.Read more

Expecting November 4 th this year to be a pivot point as the Canadian government brings out its new budget. That lines up with the rcmp corridor 2km wide x 500 feet high for a distance covering manatoba eastern boundary to Alberta western boundary.Read more